Recruiting Angelman Syndrome Studies in Chapel Hill
About Angelman Syndrome Clinical Trials in Chapel Hill
Angelman syndrome is a rare genetic disorder primarily affecting the nervous system, characterized by severe developmental delays, speech impairment, seizures, and a happy demeanor. It is caused by loss of function of the UBE3A gene. Treatment focuses on managing symptoms and maximizing developmental potential.
There are currently 1 angelman syndrome clinical trials recruiting participants in Chapel Hill, NC. These studies are seeking a combined 165 participants. Research is being sponsored by OHB Pediatrics Ltd.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Angelman Syndrome Clinical Trials in Chapel Hill — FAQ
Are there angelman syndrome clinical trials in Chapel Hill?
Yes, there are 1 angelman syndrome clinical trials currently recruiting in Chapel Hill, NC. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Chapel Hill?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chapel Hill research site will contact you about next steps.
Are clinical trials in Chapel Hill free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chapel Hill studies also compensate for your time and travel.
What angelman syndrome treatments are being tested?
The 1 active trials in Chapel Hill are testing new therapies including novel drugs, biologics, and treatment approaches for angelman syndrome.
Data updated October 15, 2026 from ClinicalTrials.gov